Skip to content

Using Fascia Lata Membrane Versus Connective Tissue Graft in Immediate Implants

Vestibular Socket Therapy Using Fascia Lata Membrane Versus Connective Tissue Graft in Immediate Implants of Aesthetic Zone

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05194826
Enrollment
20
Registered
2022-01-18
Start date
2021-06-01
Completion date
2022-03-30
Last updated
2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Aesthetic Zone, Connective Tissue Graft

Brief summary

The aim of this study is to evaluate and compare the Vestibular Socket Therapy (VST) technique using fascia lata membrane versus connective tissue graft both with xenogenic lamina membrane in immediate implants of anterior aesthetic zone.

Interventions

PROCEDURETest

immediate implant and VST with fascia lata membrane + xenogenic lamina membrane and particulate bone graft composed of autogenous cortical chips harvested from the surgical site

PROCEDUREControl

immediate implant and VST with connective tissue graft + xenogenic lamina membrane and particulate bone graft composed of autogenous cortical chips harvested from the surgical site

Sponsors

Hams Hamed Abdelrahman
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Class II socket according to Elian et al, described as facial soft tissue is present but the buccal plate is partially missing following extraction of the tooth in the maxillary anterior region. * Thin gingival phenotype. * Bone quality ranges from D2-D3 as gained from preoperative cone-beam computed tomography. * Presence of at least 3 mm of keratinized gingiva. * Optimal compliance as evidenced by no missing treatment appointments and a positive attitude towards oral hygiene

Exclusion criteria

* Medically compromised patients and systemic conditions precluding implant and periodontal surgery. * Smokers, diabetics, pregnant or lactating women. * History of chemotherapy, radiotherapy in head and/or neck region. * Bisphosphonate therapy.

Design outcomes

Primary

MeasureTime frameDescription
Changes in peri-implant mucosal levelat baseline, 6 months and 12 monthsThe changes in peri-implant mucosal level will be assessed by superimposition of scanning files of different intervals to monitor the changes in surface area calculated by software.
Changes in gingival phenotypeat baseline, 6 months and 12 monthsThe changes in gingival phenotype could be assessed at 6 months and 12 months intervals by superimposition of DICOM files on CBCT software.
Chaneg in height of labial (facial) plate of boneat baseline, 6 months and 12 monthsCone beam computed tomography (CBCT)
Chaneg in thickness of labial (facial) plate of boneat baseline, 6 months and 12 monthsCone beam computed tomography (CBCT)

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026